Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Preliminary data show effects on sleep and memory with ramelteon in Parkinson's disease patients

March 19, 2009

NST-0021 prevents neurodegeneration in vivo in Alzheimer's model

March 19, 2009

Pimavanserin does not worsen parkinsonism in patients with PD and psychosis

March 19, 2009

CytRx's arimoclomol improves stroke recovery in preclinical trial in rats

March 18, 2009

Memantine beneficial in patients with Parkinson's disease dementia or dementia with Lewy bodies

March 18, 2009

Servier claims novel napthalene derivatives that inhibit melatonin receptors

March 18, 2009

Prolonged-release ropinirole improves symptom control in Parkinson's patients

March 18, 2009

Avanir completes enrollment into phase III STAR trial of Zenvia in PBA

March 17, 2009

Durect reports phase IIb results for Transdur-Sufentanil in pain

March 17, 2009

XenoPort receives milestone payments for FDA acceptance of Solzira NDA

March 17, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...